These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12019673)

  • 1. Resolution of hyperglycemia on risperidone discontinuation: a case report.
    Mallya A; Chawla P; Boyer SK; DeRosear L
    J Clin Psychiatry; 2002 May; 63(5):453-4. PubMed ID: 12019673
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of risperidone on ghrelin and glucose in schizophrenia.
    Cohen D
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):576. PubMed ID: 17875041
    [No Abstract]   [Full Text] [Related]  

  • 3. Newer antipsychotics and glucose metabolism: a comparison between olanzapine and risperidone.
    Filaković P; Laufer D; Radanović-Grgurić L; Koić O; Fijacko M; Durković M
    Psychiatr Danub; 2005 Jun; 17(1-2):63-6. PubMed ID: 16395845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of antipsychotic-induced hyperglycemia in a child with insulin dependent diabetes mellitus.
    Stern AP; Trieu ML
    J Child Adolesc Psychopharmacol; 2012 Oct; 22(5):403-4. PubMed ID: 23083030
    [No Abstract]   [Full Text] [Related]  

  • 5. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP; Czobor P; Volavka J; Citrome L; Sheitman B; McEvoy JP; Cooper TB; Chakos M; Lieberman JA
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical antipsychotic prescribing and diabetes.
    Agius M; Murphy CL; Win A; Zaman R
    Psychiatr Danub; 2007 Jun; 19(1-2):89-90. PubMed ID: 17603422
    [No Abstract]   [Full Text] [Related]  

  • 7. Do certain atypical antipsychotics increase the risk of diabetes? A critical review of 17 pharmacoepidemiologic studies.
    Ramaswamy K; Masand PS; Nasrallah HA
    Ann Clin Psychiatry; 2006; 18(3):183-94. PubMed ID: 16923657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone induced galactorrhea: a case analysis.
    Hariharan J; Mohsin J
    WMJ; 2002; 101(8):41-3. PubMed ID: 12557612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risperidone alternative for a schizophrenic patient with olanzapine-exacerbated diabetic mellitus.
    Wu PL; Lane HY; Su KP
    Psychiatry Clin Neurosci; 2006 Feb; 60(1):115-6. PubMed ID: 16472369
    [No Abstract]   [Full Text] [Related]  

  • 10. Hyperprolactinemia with low dose of risperidone in a young female.
    Boothby A; Shad MU
    Asian J Psychiatr; 2017 Jun; 27():69-70. PubMed ID: 28558899
    [No Abstract]   [Full Text] [Related]  

  • 11. Diabetes resolution following discontinuation of a second-generation antipsychotic.
    Strassnig M; Awerbuck J; Ganguli R
    Clin Schizophr Relat Psychoses; 2013 Jan; 6(4):202-3. PubMed ID: 23302450
    [No Abstract]   [Full Text] [Related]  

  • 12. Risperidone-associated increase in triglyceride levels.
    Weinbrenner A; Peus V; Inta D; Englisch S; Zink M
    Am J Psychiatry; 2009 Jan; 166(1):113-4. PubMed ID: 19122019
    [No Abstract]   [Full Text] [Related]  

  • 13. A retrospective comparison of weight, lipid, and glucose changes between risperidone- and olanzapine-treated inpatients: metabolic outcomes after 1 year.
    Meyer JM
    J Clin Psychiatry; 2002 May; 63(5):425-33. PubMed ID: 12019668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful risperidone rechallenge after blepharospasm in a patient with schizophrenia: 24-month follow-up.
    Gulati S; Singh AN; Libretto SE
    J Psychopharmacol; 2003 Dec; 17(4):453-4. PubMed ID: 14870960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Risperidone and edema: apropos of a case].
    Masson M; Elayli R; Verdoux H
    Encephale; 2000; 26(3):91-2. PubMed ID: 10951912
    [No Abstract]   [Full Text] [Related]  

  • 16. [Blood glucose in chronic schizophrenic patients treated with antipsychotics].
    Wetterling T; Schneider B; Weber B
    Psychiatr Prax; 2007 Mar; 34(2):76-80. PubMed ID: 17160751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance index and counter-regulatory factors during olanzapine or risperidone administration in subjects with schizophrenia.
    Baptista T; Martinez M; Lacruz A; Arellano A; Mendoza S; Beaulieu S; Hernández L; Contreras Q; Galeazzi T; Vargas D
    Schizophr Res; 2007 Jan; 89(1-3):350-2. PubMed ID: 17029751
    [No Abstract]   [Full Text] [Related]  

  • 18. Diabetes associated with atypical antipsychotic treatment may be severe but reversible: case report.
    Dibben CR; Kalavalapalli SS; Linnington HE; Hynes FA; Dinneen SF; Adler AI; McKenna PJ
    Int J Psychiatry Med; 2005; 35(3):307-11. PubMed ID: 16480245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Remission of drug-induced hepatitis after switching from risperidone to paliperidone.
    Paulzen M; Orfanos S; Gründer G
    Am J Psychiatry; 2010 Mar; 167(3):351-2. PubMed ID: 20194492
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone-induced tardive dyskinesia.
    Hong KS; Cheong SS; Woo JM; Kim E
    Am J Psychiatry; 1999 Aug; 156(8):1290. PubMed ID: 10450277
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.